Prospects of stem cell treatment in benign urological diseases.
10.4111/kju.2015.56.4.257
- Author:
Amjad ALWAAL
1
;
Ahmed A HUSSEIN
;
Ching Shwun LIN
;
Tom F LUE
Author Information
1. Department of Urology, University of California, San Francisco, CA, USA. amjadwal@yahoo.com
- Publication Type:Review
- Keywords:
Erectile dysfunction;
Infertility;
Stem cells;
Urinary incontinence
- MeSH:
Erectile Dysfunction/physiopathology/*therapy;
Female;
Humans;
Male;
Outcome Assessment (Health Care);
Stem Cell Transplantation/*methods;
Urinary Incontinence/physiopathology/*therapy
- From:Korean Journal of Urology
2015;56(4):257-265
- CountryRepublic of Korea
- Language:English
-
Abstract:
Stem cells (SCs) are undifferentiated cells that are capable of self-renewal and differentiation and that therefore contribute to the renewal and repair of tissues. Their capacity for division, differentiation, and tissue regeneration is highly dependent on the surrounding environment. Several preclinical and clinical studies have utilized SCs in urological disorders. In this article, we review the current status of SC use in benign urological diseases (erectile dysfunction, Peyronie disease, infertility, and urinary incontinence), and we summarize the results of the preclinical and clinical trials that have been conducted.
